In previous work, knocking down the PI5P4Kα and PI5P4Kβ isoforms in TP53-mutant breast cancer cells inhibits cell viability, and that deletion of the enzymes in mice suppresses tumor formation with Trp53 deletion (2). This evidence concerns the gene PIP4K2A and neoplasm.